Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.

Bruce W BodeVioleta IotovaMargarita KovarenkoLori M B LaffelPaturi V RaoSrikanth DeenadayalanMagnus EkelundSteffen Falgreen LarsenThomas P A Danne

Published in: Diabetes care (2019)

In children and adolescents with type 1 diabetes, mealtime and postmeal faster aspart with insulin degludec provided effective glycemic control with no additional safety risks versus IAsp. Mealtime faster aspart provided superior HbA1c control compared with IAsp.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
clinical trial
study protocol
risk assessment
skeletal muscle
adipose tissue
climate change
metabolic syndrome
phase ii